Family Medicine · Glen Rose, TX
NPI
1073516704
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
507 SW Big Bend Trl
Glen Rose, TX, 76043
Phone (254) 897-3444
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
3,033 services
Medicare patients, 2024
339
Average age 74
Drug cost, 2024
$1.6M
16,661 prescriptions
Company payments, 2025
$722
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Schmidt was code 99214 (office e&m - established), 673 times for 302 patients. In total Paul A Schmidt billed 3,033 services in 59 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 673 | 302 | $78.88 | $53K |
| 36415 Venipuncture Blood Collection | Office | 367 | 218 | $8.65 | $3,175 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 232 | 232 | $126.60 | $29K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 157 | 157 | $18.28 | $2,870 |
| 80053 Clinical Chemistry | Office | 140 | 130 | $10.35 | $1,449 |
| 85025 Blood Count | Office | 140 | 130 | $7.61 | $1,065 |
| 80061 Clinical Chemistry | Office | 134 | 126 | $13.12 | $1,758 |
| 96372 Injection Administration | Office | 123 | 21 | $9.28 | $1,141 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 121 | 121 | $18.28 | $2,212 |
| 84443 Clinical Chemistry | Office | 115 | 107 | $16.46 | $1,893 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 106 | 12 | $0.06 | $6.74 |
| 83036 Blood Count | Office | 54 | 51 | $9.52 | $514 |
| 82306 Clinical Chemistry | Office | 47 | 47 | $29.01 | $1,363 |
| 99213 Office E&M - Established | Office | 44 | 40 | $52.71 | $2,319 |
| G0008 Administration of influenza virus vaccine | Office | 33 | 33 | $30.38 | $1,003 |
By year: 2022 $154K for 4,131 services; 2023 $138K for 4,054 services; 2024 $117K for 3,033 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 367 | 218 | $8.65 | $3,175 |
| 85025 Blood Count | 140 | 130 | $7.61 | $1,065 |
| 80053 Clinical Chemistry | 140 | 130 | $10.35 | $1,449 |
| 80061 Clinical Chemistry | 134 | 126 | $13.12 | $1,758 |
| 84443 Clinical Chemistry | 115 | 107 | $16.46 | $1,893 |
| 83036 Blood Count | 54 | 51 | $9.52 | $514 |
| 82306 Clinical Chemistry | 47 | 47 | $29.01 | $1,363 |
| 82607 Clinical Chemistry | 30 | 29 | $14.78 | $443 |
| 81003 Clinical Chemistry | 29 | 23 | $2.20 | $63.8 |
| 84403 Clinical Chemistry | 19 | 19 | $25.29 | $481 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Schmidt prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,040 prescriptions and refills. In total Paul A Schmidt wrote 16,661 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,040 | 2,828 | 290 | $12K |
| Atorvastatin Calcium Generic | 718 | 1,779 | 190 | $5,669 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 661 | 665 | 114 | $18K |
| Alprazolam Generic | 422 | 496 | 75 | $3,201 |
| Metoprolol Succinate Generic | 380 | 909 | 101 | $4,887 |
| Pantoprazole Sodium Generic | 369 | 779 | 92 | $3,401 |
| Lisinopril Generic | 352 | 934 | 106 | $2,364 |
| Tamsulosin Hcl Generic | 304 | 756 | 85 | $3,928 |
| Amlodipine Besylate Generic | 302 | 852 | 92 | $2,077 |
| Gabapentin Generic | 292 | 555 | 77 | $6,651 |
| Montelukast Sodium Generic | 258 | 616 | 79 | $2,589 |
| Metformin Hcl Generic | 250 | 623 | 65 | $2,053 |
| Finasteride Generic | 247 | 665 | 70 | $2,985 |
| Furosemide Generic | 242 | 460 | 68 | $1,123 |
| Losartan Potassium Generic | 237 | 617 | 76 | $2,015 |
Brand drugs: 2,316 claims; generic drugs: 14,184 claims; opioid claims: 1,071.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Schmidt $722 ($722 in general payments such as food, travel and fees) from 16 companies. The largest payer was Supernus Pharmaceuticals, Inc. with $86.36.
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. SUPN | 4 | $86.36 |
| Abbvie Inc. ABBV | 5 | $83.91 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $82.47 |
| Axsome Therapeutics, Inc. AXSM | 3 | $67.68 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $66.62 |
| Exact Sciences Corporation EXAS | 3 | $58.48 |
| Novo Nordisk Inc NVO | 3 | $54.09 |
| Dexcom, Inc. DXCM | 2 | $43.31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $35.42 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $33.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.